Marinus Pharmaceuticals
-
Marinus Therapeutics in Radnor Acquired by Swedish Company
Marinus Pharmaceuticals, based in Radnor, is being acquired by Immedica Pharma, a Swedish drug company specializing in treatments for rare diseases, writes John George for…
-
2 Delaware County Tech Firms Among Fastest Growing in Nation
Seven Philadelphia-area companies made the 2024 Deloitte Technology Fast 500 list, including two from Delaware County, writes Ryan Mulligan for Philadelphia Business Journal. Deloitte’s 30th…
-
Marinus Pharmaceuticals Loses 80 Percent Market Value Over New Drug
Marinus Pharmaceuticals of Radnor saw its stock price plunge by more than 80 percent Monday because of a setback in an experimental seizure drug, writes…
-
2 Linked to Delaware County Make List of Most Admired CEOs for 2022
The president of Cheyney University and the CEO of Radnor-based Marinus Pharmaceuticals made a Philadelphia Business Journal list of the 26 most admired CEOs in…
-
Radnor Biotech CEO Scott Braunstein on Top 25 Biotech CEO List for 2022
The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled by The…
-
Radnor Pharmaceutical, Marinus, Plans Stock Sale This Week
A Radnor pharmaceutical company specializing in new therapies for rare seizure disorders is raising $70 million through a public stock offering this week, writes John…
-
Radnor’s Marinus Pharmaceuticals Aims to Generate $35 Million from Public Stock Offering
Radnor’s Marinus Pharmaceuticals is looking to raise $35 million from its public offering of 9.3 million shares of its common stock priced at $3.75 per…
-
Radnor Pharma Company Gets Head Start on Treating Fragile X in Children
Marinus Pharmaceuticals in Radnor is getting a jumpstart over the competition in the race to develop a treatment for the rare, autism-like Fragile X Syndrome…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
